Showing 1-50 of 55 Per page: 50 100
Name Art no Species Reactivity Application Conjugation Clone Size Price
SIM0021-5MG
human
Block, ELISA, FA
Avelumab
5 mg
CP168-25MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM-CP168
25 mg
CP168-5MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM-CP168
5 mg
BE0101-100MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM
100 mg
BE0101-1MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM
1 mg
SIM0021-50MG
human
Block, ELISA, FA
Avelumab
50 mg
SIM0021-100MG
human
Block, ELISA, FA
Avelumab
100 mg
BP0101-50MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM
50 mg
SIM0009-5MG
human
FC, WB
Unconjugated
Atezolizumab
5 mg
SIM0009-100MG
human
FC, WB
Unconjugated
Atezolizumab
100 mg
BE0390-1MG
dog/canine
Block, FA, FC, WB
JC071
1 mg
BE0285-100MG
human
Block, FA, FC, IHC
Unconjugated
29E.2A3
100 mg
BE0285-25MG
human
Block, FA, FC, IHC
Unconjugated
29E.2A3
25 mg
SIM0027-100MG
human
ELISA, FA, FC, WB
Durvalumab
100 mg
BE0101-50MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM
50 mg
SIM0027-25MG
human
ELISA, FA, FC, WB
Durvalumab
25 mg
BE0361-50MG
mouse
Block, ELISA, FC
Unconjugated
10F.2H11
50 mg
BE0361-100MG
mouse
Block, ELISA, FC
Unconjugated
10F.2H11
100 mg
BE0383-5MG
human, mouse, rat
Block, FC
Unconjugated
368A.4H1
5 mg
BE0390-100MG
dog/canine
Block, FA, FC, WB
JC071
100 mg
BE0390-5MG
dog/canine
Block, FA, FC, WB
JC071
5 mg
SIM0021-1MG
human
Block, ELISA, FA
Avelumab
1 mg
BE0101-5MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM
5 mg
CP168-100MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM-CP168
100 mg
CP168-50MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM-CP168
50 mg
CP168-1MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM-CP168
1 mg
BE0285-50MG
human
Block, FA, FC, IHC
Unconjugated
29E.2A3
50 mg
BE0285-5MG
human
Block, FA, FC, IHC
Unconjugated
29E.2A3
5 mg
BE0361-25MG
mouse
Block, ELISA, FC
Unconjugated
10F.2H11
25 mg
BE0361-1MG
mouse
Block, ELISA, FC
Unconjugated
10F.2H11
1 mg
SIM0009-1MG
human
FC, WB
Unconjugated
Atezolizumab
1 mg
BE0361-5MG
mouse
Block, ELISA, FC
Unconjugated
10F.2H11
5 mg
BE0383-1MG
human, mouse, rat
Block, FC
Unconjugated
368A.4H1
1 mg
BE0383-50MG
human, mouse, rat
Block, FC
Unconjugated
368A.4H1
50 mg
BE0383-100MG
human, mouse, rat
Block, FC
Unconjugated
368A.4H1
100 mg
BE0383-25MG
human, mouse, rat
Block, FC
Unconjugated
368A.4H1
25 mg
BE0390-50MG
dog/canine
Block, FA, FC, WB
JC071
50 mg
BE0390-25MG
dog/canine
Block, FA, FC, WB
JC071
25 mg
BE0101-25MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM
25 mg
SIM0021-25MG
human
Block, ELISA, FA
Avelumab
25 mg
SIM0027-50MG
human
ELISA, FA, FC, WB
Durvalumab
50 mg
SIM0027-5MG
human
ELISA, FA, FC, WB
Durvalumab
5 mg
SIM0027-1MG
human
ELISA, FA, FC, WB
Durvalumab
1 mg
BP0101-5MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM
5 mg
BP0101-100MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM
100 mg
BP0101-25MG
mouse
Block, FC, IF, IHC, WB
Unconjugated
10F.9G2TM
25 mg
BE0285-1MG
human
Block, FA, FC, IHC
Unconjugated
29E.2A3
1 mg
SIM0009-25MG
human
FC, WB
Unconjugated
Atezolizumab
25 mg
SIM0009-50MG
human
FC, WB
Unconjugated
Atezolizumab
50 mg
CP001-1MG
mouse
Block, FC, IF, IHC, WB
10F.9G2TM-CP001
1 mg
News November 01 2016

PD-L1 & ALK Positive Control for IHC